Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty

Journal of Cardiology

Volumn 44, Issue 1, 2004, Pages 13-20

  Shiraki, Teruo ^a   Takamura, Toshiyuki ^a   Kajiyama, Akio ^a   Oka, Takefumi ^a   Saito, Daiji ^a  

^a IWAKUNI NATIONAL HOSPITAL   (Japan)

Author keywords

Angioplasty (PTCA); Myocardial infarction, treatment; Nitric oxide (L arginine administration); Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; CALCIUM ANTAGONIST; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISOSORBIDE DINITRATE; LONG ACTING DRUG; NIFEDIPINE; NITRATE; NITRIC OXIDE; NITRITE; TICLOPIDINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART CATHETER; HEART INFARCTION; HUMAN; INTRACORONARY INFUSION; MALE; QUANTITATIVE DIAGNOSIS; RESTENOSIS; SHORT COURSE THERAPY; SINGLE DRUG DOSE; SYSTEMIC THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY; BLOOD; DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARGININE; CORONARY RESTENOSIS; CYCLIC GMP; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE;

EID: 4644354003     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Pompa JJ, Califf RM, Topol EJ: Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436
2. Liu MW, Roubin GS, King SBI III: Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374-1387
3. Lafont A, Faxon D: Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Cardiovasc Res 1998; 39: 50-59
4. Serruys PW, de Jaegere P, Kiemenneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. Belardi J, Sigwart U, Colombo A, Goy JJ, Heuvel P, Delcan J, Morel M, for the Benestent Study Group: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495
5. Fishman DL, Leon MB, Baim DS, Schatz RA. Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Godberg S, for the Stent Restenosis Study Investigators: A randomized comparison of coronary-stem placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501
6. Hoffmann R, Mintz GS. Dussaillant GR, Pompa JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanism of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254
7. Teirstein PS, Massulllo V, Jani S, Pompa JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-1703
8. 32P radioactive β-emiting stents. Circulation 2000; 101: 2454-2457
9. Costa MA, Sabat M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JMR, Serrano P, Coen VL, Levendag PC, Serruys PW: Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100: 789-792
10. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa A, Falotico R, Jaeger J, Pompa JJ, Serruys PW: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravscular ultrasound study. Circulation 2001; 103: 192-195
11. Liistro F, Stankovic MD, Di Mario C, Takagi T, Chieffo A, Moshiri S, Montorfano M, Carlino M, Briguori C, Pagnotta P, Albiero R, Corvaja N, Colombo A: First clinical experience with a paclitaxel redivate-eluting polymer stent system implantation for in-stent restenosis: Immediate and long-term clinical and angiographic outcome. Circulation 2002; 105: 1883-1886
12. Wang BY, Candipan RC, Arjomandi M. Hsiun PT, Tsao PS, Cooke JP: Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996; 28: 1573-1579
13. Goves PH, Lewis MJ, Cheadle HA, Penny WJ: SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993; 87: 590-597
14. Furlong B, Henderson AM, Lewis MJ, Smith JA: Endothelium-derived-relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-692
15. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88: 4651-4655
16. Garg UC, Hassid A: Nitric-oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777
17. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-1121
18. Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438
19. Schwarzacher SP, Lim TT, Wang B, Kernoff RS, Niebauer J, Cooke JP, Yeung AC: Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997; 95: 1863-1869
20. Niebauer J, Schwarzacher SP, Hayase M, Wang B, Kernoff RS, Cooke JP, Yeung AC: Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999; 100: 1830-1835
21. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL: L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 1993; 193: 291-296
22. Greenless C, Wadsworth RM, Martorana PA, Wainwright CL: The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits. Cardiovasc Res 1997; 35: 351-359
23. Myer RP, Webel R, Thondapu V, Xu VT, Amann J, Tanner MA, Jenkins JS, Pollock JS, Jaughlin MH: Restenosis associated with decreased coronary artery nitric syntase. Int J Cardiol 1995; 55: 183-191
24. Bosmans JM, Bult H, Vrints CJ, Kockx MM, Herman AG: Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries. Eur J Pharmacol 1996; 310: 163-174
25. Joly GA, Schini VB, Vanhoutte PM: Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res 1992; 71: 331-338
26. Lerman A, Burnett JC Jr, Higano ST, McKinley LJ, Holmes DR Jr: Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97: 2123-2128
27. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP: Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847
28. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-3095
29. Kaye DM, Ahlers BA, Autelitano DJ, Chin-Dusting PF: In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation 2000; 102: 2707-2712
30. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A: Effect of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996; 94: 130-134
31. Drexler H, Zeiher AM, Meinzer K, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-1550
32. Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes P: The L-arginine: Nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 1995; 209: 590-596
33. Lundberg JON, Weitzberg E, Lundberg JM, Alving K: Intragastric nitric oxide production in humans: Measurements in expelled air. Gut 1994; 35: 1543-1546
34. Dudek D, Heba G, Bartus S, Partyka U, Dembinska-Kiec A, Huk J, Legutko J, Dibiel JS: Effects of L-arginine supplementation on endothelial function after stent implantation. Kardiol Pol 2002; 57: 389-398
35. Le Tourneau T, Van Belle E, Corseaux D, Vallet B, Lebuffeg G, Dupuis B, Lablanche JM, McFadden E, Bauters C, Bertrand M: Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: Effects on neointimal hyperplasia and vascular remodeling. J Am Coll Cardiol 1999; 33: 876-882
36. Kim YM, Bombeck CA, Billar TR: Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999; 84: 253-256